Sorrento Therapeutics, Inc. - SRNE

Detailed investor-level table based on 13F positions.
Early Q4 2025 data: only 5 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.

Shareholders (13F)

Quarter: Q1 2023
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
SIMPLEX TRADING, LLC History New 291,700 104 0.0% 1 +291,700 New Q1 2023 Apr 27, 2023
OAKTREE CAPITAL MANAGEMENT LP History New 134,000 48 0.0% 2 +134,000 New Q1 2023 Aug 25, 2023
Valeo Financial Advisors, LLC History New 27,473 9 0.0% 3 +27,473 New Q1 2023 Apr 17, 2023
HUNTINGTON NATIONAL BANK History New 14,001 5 0.0% 4 +14,001 New Q1 2023 May 10, 2023
Tower Research Capital LLC (TRC) History New 8,316 3 0.0% 5 +8,316 New Q1 2023 May 09, 2023
CREDIT AGRICOLE S A History New 7,000 2 0.0% 6 +7,000 New Q1 2023 May 15, 2023
BAILLIE GIFFORD & CO History New 3,711 1 0.0% 8 +3,711 New Q1 2023 May 03, 2023
NISA INVESTMENT ADVISORS, LLC History New 2,886 1 0.0% 7 +2,886 New Q1 2023 May 02, 2023
Steward Partners Investment Advisory, LLC History New 2,000 0 +2,000 New Q1 2023 May 15, 2023
Russell Investments Group, Ltd. History New 266 0 +266 New Q1 2023 May 09, 2023
JPMORGAN CHASE & CO History New 1 0 +1 New Q1 2023 May 18, 2023